Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.
Start price
14.03.24
/
50%
€15.01
Target price
14.03.25
€24.74
Performance (%)
-8.26%
Price
23.04.24
€13.77
Summary
This prediction is currently active. With a performance of -8.26%, the BUY prediction for Catalyst Pharmaceutical Partners Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 14.03.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -5.782% | -5.782% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Citigroup_Inc_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat